New CBI boss says she is ‘profoundly sorry’ to women let down by business group – live
TheGuardian
APRIL 26, 2023
As Rain Newton-Smith takes over as CBI director general, the boss of drugmaker GSK calls claims around CBI ‘absolutely shocking’ and ‘repulsive’ Revenues at GSK , Britain’s second-biggest drugmaker, slid in the first quarter because of a 98% drop in sales of its Covid-19 treatment Xevudy. The US regulator withdrew its authorisation for the drug in late January , saying it doesn’t work on the new dominant strains of the virus.
Let's personalize your content